Induction of interleukin-12 production in chronic hepatitis C virus infection correlate with the hepatocellular damage

Journal of Infectious Diseases

Volumn 178, Issue 1, 1998, Pages 247-251

  Quiroga, Juan Antonio ^a   Martín, Julio ^a   Navas, Sonia ^a   Carreño, Vicente ^a,b  

^a Hospital Pardo De Aravaca   (Spain)

^b Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA2B INTERFERON; GAMMA INTERFERON; INTERLEUKIN 12;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HEPATITIS C; HISTOPATHOLOGY; HOST RESISTANCE; HUMAN; IMMUNOPATHOGENESIS; LIVER CELL DAMAGE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; VIREMIA; VIRUS LOAD;

EID: 0031844841     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517446     Document Type: Article

References (15)

1. Trinchieri G. Interleukin-12: a cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes. Blood 1994;84:4008-27.
2. Gately MK, Mulqueen MJ. Interleukin-12: potential clinical applications in the treatment and prevention of infectious diseases. Drugs 1996;52(suppl 2):18-26.
3. Hayes MP, Wang J, Norcross MA. Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes. Blood 1995;86:646-50.
4. Ferrari C, Valli A, Galati L, et al. T-cell response to structural and non-structural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994;19:286-95.
5. + T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology 1995;21:632-8.
6. Reherman B, Chang KM, McHutchison JG, et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol 1996;70:7092-102.
7. Nelson DR, Marousis CG, Davis GL, et al. The role of hepatitis C virus-specific cytotoxic T lymphocytes in chronic hepatitis C. J Immunol 1997;158:1473-81.
8. Hoofnagle JH, Di Bisceglie AM. The treatment of chronic viral hepatitis. N Engl J Med 1997;336:347-56.
9. Navas S, Castillo I, Martín J, Quiroga JA, Bartolomé J, Carreño V. Concordance of hepatitis C virus typing methods based on RFLP analysis in 5′ non-coding region, and NS4 serotyping, but not in core-PCR or a line probe assay. J Clin Microbiol 1997;35:317-21.
10. Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981;1:431-5.
11. Desmet VJ, Gerber MA, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994;19:1513-20.
12. Zhang M, Gately MK, Wang E, et al. Interleukin 12 at the site of disease in tuberculosis. J Clin Invest 1994;93:1733-9.
13. Chehimi J, Starr SE, Frank I, et al. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994;179:1361-6.
14. Kakumu S, Okumura A, Ishikawa T, Iwata K, Yano M, Yoshioka K. Production of interleukins 10 and 12 by peripheral blood mononuclear cells (PBMC) in chronic hepatitis C virus (HCV) infection. Clin Exp Immunol 1997;108:138-43.
15. Rossol S, Marinos G, Carucci P, Singer MV, Williams R, Naoumov NV. Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 1997;99:3025-33.